New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
07:34 EDTNAVBNavidea, collaborators announce NAV4694 presentations
Navidea Biopharmaceuticals announced that collaborators from the Department of Nuclear Medicine at University Hospital of Leipzig are planning presentations highlighting Navidea’s PET imaging agent, NAV4694, at the German Society of Nuclear Medicine Annual Congress in Hannover, Germany. NAV4694 is an investigational Fluorine-18 labeled beta-amyloid imaging agent currently being evaluated in late stage clinical trials for use as an aid in differential diagnosis and to monitor progression of Alzheimer's disease, Mild Cognitive Impairment and other forms of neurodegenerative dementia.
News For NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
07:32 EDTNAVBNavidea awarded $1.8M grant for evaluation of Manocept agent in Kaposi's Sarcoma
Subscribe for More Information
September 2, 2015
07:33 EDTNAVBNavidea announces dual listing on Tel Aviv Stock Exchange
Navidea Biopharmaceuticals announced that the Tel Aviv Stock Exchange has approved the new listing of Navidea's common stock on the TASE beginning on Tuesday, September 8 under the ticker symbol NAVB. The company's common stock will be listed on both the NYSE MKT in the United States and the TASE in Israel. The company also announced that, based upon Navidea's current market capitalization, it expects its shares to be subject to inclusion in five TASE equity indexes.
07:27 EDTNAVBSidoti to hold a conference
2015 Sidoti Emerging Growth Conference is being held in New York on September 2.
August 24, 2015
07:32 EDTNAVBNavidea to register shares for dual listing on TASE
Navidea Biopharmaceuticals announced that it has filed an application for registration of shares of its common stock for dual listing on the Tel-Aviv Stock Exchange, or TASE. Dual listing on the TASE is allowed in the U.S. and Israel without any additional regulatory requirements for companies whose shares are listed on certain accredited stock exchanges outside of Israel, including the NYSE MKT.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use